BENJAMIN WITT: Open Payments
NPI 1427565084 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,206 in 103 payments from 16 companies in 2025. Trend: 2023 $605 · 2024 $1,058 · 2025 $2,206
Food & beverage: $2,122Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $855 |
| Lilly USA, LLC | 13 | $219 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $214 |
| Janssen Biotech, Inc. | 6 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $149 |
| Phathom Pharmaceuticals, Inc. | 6 | $108 |
| Madrigal Pharmaceuticals | 5 | $99 |
| Celltrion USA Inc. | 4 | $83 |
| Intercept Pharmaceuticals, Inc. | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 3 | $60 |
Products named: RINVOQ, OMVOH, XIFAXAN, MAVYRET, TREMFYA, ENTYVIO, VOQUEZNA, REZDIFFRA.
Industry payments across MO — which companies pay providers there.
